Ambulatory Cardiac Monitoring Devices Market Size & Growth Forecast 2026–2035, By Segments (End-use, Device Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Ambulatory Cardiac Monitoring Devices Market size was estimated at USD 7.59 Billion in 2025 and is projected to grow at a 10.4% CAGR from 2026 to 2035, reaching USD 20.41 Billion by 2035. The industry revenue for 2026 is assessed at USD 8.29 billion.

• Base Year Value (2025): USD 7.59 Billion
• CAGR (2026-2035): 10.4%
• Forecast Year Value (2035): USD 20.41 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Ambulatory Cardiac Monitoring Devices Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held a 45.37% share in 2025, supported by established cardiac care pathways and widespread integration of wearable monitoring into clinical practice.
  • Asia Pacific is expected to expand at an 11.65% CAGR, driven by mobile diagnostics adoption and broader access to outpatient cardiac monitoring.

• Segment Momentum:

  • Hospitals held a 53.03% market share in 2025 due to their concentration of cardiology expertise, established monitoring workflows, and ongoing demand for structured cardiac assessment and follow-up care.
  • Mobile cardiac telemetry is the fastest-growing device type because it enables responsive, continuous monitoring and captures irregular cardiac events that may be missed during shorter monitoring periods.

• Market Expansion Drivers:

  • Rising prevalence of cardiac disorders increasing demand for continuous remote heart monitoring solutions.
  • Growing adoption of remote patient monitoring strengthening mobile cardiac telemetry device utilization.
  • Expanding healthcare digitization improving integration of wearable cardiac monitoring technologies.

• Leading Market Participants:

  Key players in the ambulatory cardiac monitoring devices market include Abbott Laboratories (United States), iRhythm Technologies, Inc. (United States), GE HealthCare Technologies Inc. (United States), Biotronik SE & Co. KG (Germany), Nihon Kohden Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (United States), ZOLL Medical Corporation (United States), Fukuda Denshi Co., Ltd. (Japan), Baxter International Inc. (Hill-Rom Holdings, Inc.) (United States).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 7.59 Billion
  • Projected Market Size: USD 20.41 Billion by 2035
  • Growth Forecasts: 10.4% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Hospitals (End-use) | Holter Monitors (Device Type)
  • Emerging Opportunity Segment: Homecare Settings (End-use) | Mobile Cardiac Telemetry (Device Type)

Market Growth Drivers and Industry Trends

Rising prevalence of cardiac disorders increasing demand for continuous remote heart monitoring solutions

As arrhythmias, heart failure, ischemic conditions, and other cardiovascular disorders become more common, providers are relying more heavily on devices that capture cardiac activity over longer periods than standard in-clinic testing allows. This is directly increasing demand for the ambulatory cardiac monitoring devices market because intermittent symptoms are often missed during short diagnostic windows, pushing clinicians toward patch monitors, Holter systems, and event recorders that can document episodes during normal daily activity. The practical effect is a shift in diagnostic pathways toward earlier outpatient monitoring, with hospitals, cardiology practices, and diagnostic service providers expanding use of continuous remote monitoring to reduce missed detections and improve treatment decisions without requiring prolonged inpatient observation.

Growing adoption of remote patient monitoring strengthening mobile cardiac telemetry device utilization

Remote patient monitoring programs are making mobile cardiac telemetry more attractive because care teams increasingly want near real-time visibility into patient status outside acute care settings. In the ambulatory cardiac monitoring devices market, this is influencing purchasing and deployment decisions in favor of connected systems that can transmit actionable rhythm data to clinicians, enabling faster triage of high-risk patients and more efficient follow-up workflows. As providers build virtual care models around chronic disease management and post-discharge surveillance, mobile telemetry is becoming embedded in routine cardiac oversight, supporting market expansion through stronger demand for device platforms tied to monitoring services, data review infrastructure, and clinician alert management.

Expanding healthcare digitization improving integration of wearable cardiac monitoring technologies

As healthcare systems digitize clinical records, care coordination, and patient engagement tools, wearable cardiac devices are becoming easier to incorporate into routine cardiology workflows rather than remaining stand-alone diagnostic tools. This is strengthening market development in the ambulatory cardiac monitoring devices market because interoperability with electronic health records, cloud-based review platforms, and digital communication channels reduces friction for physicians ordering tests, interpreting results, and tracking patient adherence. In practice, better integration supports broader use of wearable monitors in outpatient settings, where streamlined data transfer and interpretation make these technologies more viable for large-scale deployment and help increase market penetration among providers seeking efficient, connected cardiac monitoring pathways.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising prevalence of cardiac disorders increasing demand for continuous remote heart monitoring solutions	2.00%	High	North America, Europe	High	Near Term
Growing adoption of remote patient monitoring strengthening mobile cardiac telemetry device utilization	1.80%	Moderate	North America, Asia Pacific	High	Mid Term
Expanding healthcare digitization improving integration of wearable cardiac monitoring technologies	1.40%	Moderate	Europe, Middle East & Africa	Emerging	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the leading position in 2025, accounting for a 45.37% share of the ambulatory cardiac monitoring devices market. This regional strength is supported by established cardiac care pathways, broad use of outpatient rhythm monitoring in routine diagnosis and follow-up, and healthcare systems that are well equipped to integrate wearable and portable monitoring devices into clinical practice. Demand is aided by the practical need for continuous monitoring of arrhythmias and other cardiac events outside hospital settings, allowing providers to extend observation periods and make treatment decisions with more complete patient data.

Asia Pacific is projected to expand at an 11.65% CAGR over the forecast period in the ambulatory cardiac monitoring devices market, driven by faster adoption of mobile and portable cardiac diagnostics across a widening patient base. Growth is being impelled by rising use of ambulatory monitoring in day-to-day clinical management, as healthcare providers increasingly look for scalable ways to detect intermittent cardiac abnormalities without relying solely on in-hospital assessment. The region’s momentum also reflects expanding access to modern monitoring technologies and greater incorporation of remote and outpatient-based cardiac evaluation into regular care delivery.

Key Country Insights

United States

Remote Cardiac Care

The U.S. prioritizes ambulatory cardiac monitoring devices that support continuous patient observation beyond hospital settings. Healthcare providers increasingly integrate connected monitoring solutions into cardiac care pathways to improve diagnostic efficiency and patient management.

Japan

Aging Population Monitoring

Japan expands ambulatory cardiac monitoring device adoption to address increasing cardiovascular care requirements among older adults. Healthcare facilities in Japan focus on reliable long-duration monitoring solutions that support timely diagnosis and efficient outpatient management.

South Korea

Digital Health Integration

South Korea integrates ambulatory cardiac monitoring devices with digital healthcare platforms to enhance patient monitoring and clinical connectivity. The country's healthcare providers emphasize connected technologies that improve workflow efficiency and support remote cardiac assessment.

Germany

Precision Diagnostic Adoption

Germany emphasizes ambulatory cardiac monitoring technologies that improve diagnostic accuracy and support evidence-based cardiovascular care. German healthcare providers increasingly deploy wearable monitoring systems that strengthen long-term patient assessment and clinical decision-making.

France

Outpatient Care Optimization

France encourages ambulatory cardiac monitoring as part of broader outpatient cardiovascular management strategies. French healthcare providers adopt portable monitoring solutions that improve patient convenience while supporting earlier clinical intervention when needed.

Italy

Community-Based Cardiac Monitoring

Italy expands ambulatory cardiac monitoring through outpatient services and community healthcare settings. Italian providers increasingly utilize portable diagnostic devices that enable continuous rhythm assessment while reducing reliance on prolonged hospital observation.

Segment Leadership and Growth Trends

  End-use Segment Analysis: Hospitals (Largest Segment) vs Homecare Settings (Fastest-Growing Segment)

Hospitals held a 53.03% share of the ambulatory cardiac monitoring devices market in 2025, reflecting their continued role as the primary setting for cardiac assessment, diagnosis, and follow-up care. Leadership in this end-use segment is sustained by the concentration of cardiology specialists, established monitoring workflows, and access to a broad range of ambulatory cardiac monitoring devices for patients who require structured evaluation after symptoms, procedures, or hospital visits. Hospitals also remain the main point of care for patients with more complex cardiac risk profiles, which supports consistent device utilization and preserves their share in the market.

Homecare Settings are emerging as the fastest-growing end-use segment in the ambulatory cardiac monitoring devices market as care delivery shifts toward patient-friendly monitoring outside conventional clinical environments. Growth is being backed by rising demand for continuous rhythm tracking in less resource-intensive settings, especially where long-duration observation is more practical at home than through repeated facility visits. Compared with hospitals and other institutional settings, homecare use is gaining momentum because it better aligns with remote care models and the need for more convenient monitoring during routine daily activity.

Device Type Segment Analysis: Holter Monitors (Largest Segment) vs Mobile Cardiac Telemetry (Fastest-Growing Segment)

By 2025, Holter Monitors accounted for the largest share in the ambulatory cardiac monitoring devices market, backed by their routine use in short-term ambulatory rhythm assessment and their established place in standard cardiac diagnostic pathways. Their leadership is tied to broad clinical familiarity, dependable use for detecting intermittent arrhythmias over defined monitoring periods, and integration into hospital and outpatient cardiology practice. This consistent applicability across a wide patient base helps Holter Monitors retain their share within the market.

Mobile Cardiac Telemetry is the fastest-growing device type in the ambulatory cardiac monitoring devices market because it addresses the need for more responsive and extended monitoring than conventional episodic devices. Its momentum comes from practical advantages in capturing clinically relevant events as they occur, which is especially valuable when symptoms are irregular and may be missed during shorter monitoring windows. Relative to traditional monitoring alternatives, Mobile Cardiac Telemetry is seeing wider adoption as providers and patients increasingly favor solutions that support continuous oversight with less dependence on in-person reassessment.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
End-use	Hospitals, Ambulatory Surgical Centers, Homecare Settings, Others	Hospitals	Homecare Settings
Device Type	Holter Monitors, Event Monitors, Mobile Cardiac Telemetry, Others	Holter Monitors	Mobile Cardiac Telemetry

Competitive Landscape and Market Positioning

Top players in the ambulatory cardiac monitoring devices market:

1. Abbott Laboratories (United States)

2. iRhythm Technologies Inc. (United States)

3. GE HealthCare Technologies Inc. (United States)

4. Biotronik SE & Co. KG (Germany)

5. Nihon Kohden Corporation (Japan)

6. Koninklijke Philips N.V. (Netherlands)

7. Boston Scientific Corporation (United States)

8. ZOLL Medical Corporation (United States)

9. Fukuda Denshi Co. Ltd. (Japan)

10. Baxter International Inc. (Hill-Rom Holdings Inc.) (United States)

The ambulatory cardiac monitoring devices market is progressing through enhanced real-time cardiac tracking and diagnostic capabilities. Increasing use of wearable monitoring solutions is improving patient care efficiency. Continuous development of advanced sensor-based systems is supporting better clinical insights, while integration into healthcare networks is strengthening remote monitoring effectiveness.

Industry Development/News

Company Name	Date	Key Development
Koninklijke Philips N.V.	Feb-21	Philips acquired BioTelemetry, Inc. to enhance its cardiac diagnostics portfolio. The transaction integrates specialized Holter monitoring, Mobile Cardiac Outpatient Telemetry, and Event Recorder solutions, significantly expanding the company’s capabilities in both short-term and long-term cardiac monitoring and remote diagnostic service offerings within the U.S. market.
ZOLL Medical Corporation	2025	ZOLL Medical Corporation launched AI-assisted mobile telemetry technology designed for real-time cardiovascular event detection. This development represents a strategic push toward integrating advanced artificial intelligence capabilities into outpatient monitoring devices to improve diagnostic accuracy and enable more rapid clinical intervention for patients outside of traditional hospital settings.
Koninklijke Philips N.V.	2024	Philips introduced cloud-integrated ambulatory cardiac monitoring platforms aimed at enhancing remote patient management. By leveraging cloud connectivity, these platforms facilitate more efficient data transmission and analysis, allowing healthcare providers to manage complex cardiac monitoring workflows remotely and improving the scalability of outpatient diagnostic services.
NIHON KOHDEN CORPORATION	2024	Nihon Kohden developed lightweight, wireless Holter monitoring systems specifically engineered for long-duration outpatient use. This product advancement addresses critical clinical needs for patient comfort and compliance during extended monitoring periods, improving the technical viability of long-term ambulatory assessment in competitive cardiac care environments.
iRhythm Technologies Inc	2023	iRhythm Technologies introduced advanced, AI-driven arrhythmia detection software tailored for extended ECG monitoring. By embedding sophisticated diagnostic algorithms into its monitoring ecosystem, the company enhances its capacity for high-precision, automated clinical analysis, further differentiating its service offerings in the competitive market for long-term remote cardiac rhythm diagnostics.
Abbott	2023	Abbott expanded its portfolio of wearable cardiac monitoring solutions by incorporating smartphone-connected ECG technologies. This strategic integration enables seamless, consumer-accessible cardiac monitoring, allowing for enhanced data collection and patient engagement, while strengthening Abbott’s position in the growing segment of digital, connectivity-focused ambulatory cardiac care tools.